39 related articles for article (PubMed ID: 10694646)
1. A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma.
Zhao C; Tan T; Zhang E; Wang T; Gong H; Jia Q; Liu T; Yang X; Zhao J; Wu Z; Wei H; Xiao J; Yang C
Front Oncol; 2022; 12():1029670. PubMed ID: 36465398
[TBL] [Abstract][Full Text] [Related]
2. Sacral chordoma: clinical experience of a series of 11 patients over 18 years.
Lim JBT; Soeharno H; Tan MH
Eur J Orthop Surg Traumatol; 2019 Jan; 29(1):9-15. PubMed ID: 30066091
[TBL] [Abstract][Full Text] [Related]
3. The molecular aspects of chordoma.
Gulluoglu S; Turksoy O; Kuskucu A; Ture U; Bayrak OF
Neurosurg Rev; 2016 Apr; 39(2):185-96; discussion 196. PubMed ID: 26363792
[TBL] [Abstract][Full Text] [Related]
4. Sacral chordoma in an adult showing an aggressive clinical course: A case report.
Endo K; Yamashita H; Nagashima H; Teshima R
Oncol Lett; 2014 May; 7(5):1443-1446. PubMed ID: 24765153
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability in sarcoma: fact or fiction?
Monument MJ; Lessnick SL; Schiffman JD; Randall RT
ISRN Oncol; 2012; 2012():473146. PubMed ID: 23401795
[TBL] [Abstract][Full Text] [Related]
6. Update on the cytogenetics and molecular genetics of chordoma.
Larizza L; Mortini P; Riva P
Hered Cancer Clin Pract; 2005 Feb; 3(1):29-41. PubMed ID: 20223027
[TBL] [Abstract][Full Text] [Related]
7. Clonality studies in sacral chordoma.
Klingler L; Trammell R; Allan DG; Butler MG; Schwartz HS
Cancer Genet Cytogenet; 2006 Nov; 171(1):68-71. PubMed ID: 17074594
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics of sacral chordoma.
DeBoer JM; Neff JR; Bridge JA
Cancer Genet Cytogenet; 1992 Nov; 64(1):95-6. PubMed ID: 1458457
[TBL] [Abstract][Full Text] [Related]
9. Total resection of inferiorly located sacral chordoma with posterior only approach: case report and review of the literature.
Sabuncuoglu H; Ozdogan S; Dogan H; Ataoglu O; Tımurkaynak E
Turk Neurosurg; 2010 Oct; 20(4):527-32. PubMed ID: 20963705
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite instability in sacral chordoma.
Klingler L; Shooks J; Fiedler PN; Marney A; Butler MG; Schwartz HS
J Surg Oncol; 2000 Feb; 73(2):100-3. PubMed ID: 10694646
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability in malignant melanoma.
Talwalkar VR; Scheiner M; Hedges LK; Butler MG; Schwartz HS
Cancer Genet Cytogenet; 1998 Jul; 104(2):111-4. PubMed ID: 9666803
[TBL] [Abstract][Full Text] [Related]
12. Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1.
Rinner B; Froehlich EV; Buerger K; Knausz H; Lohberger B; Scheipl S; Fischer C; Leithner A; Guelly C; Trajanoski S; Szuhai K; Liegl B
Int J Oncol; 2012 Feb; 40(2):443-51. PubMed ID: 22002331
[TBL] [Abstract][Full Text] [Related]
13. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.
Dolan K; Garde J; Gosney J; Sissons M; Wright T; Kingsnorth AN; Walker SJ; Sutton R; Meltzer SJ; Field JK
Br J Cancer; 1998 Oct; 78(7):950-7. PubMed ID: 9764589
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
Chang HJ; Kim SW; Kim YT; Kim WH
Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
